369 related articles for article (PubMed ID: 21062863)
1. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome.
Hofmann JJ; Zovein AC; Koh H; Radtke F; Weinmaster G; Iruela-Arispe ML
Development; 2010 Dec; 137(23):4061-72. PubMed ID: 21062863
[TBL] [Abstract][Full Text] [Related]
2. Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype.
Ryan MJ; Bales C; Nelson A; Gonzalez DM; Underkoffler L; Segalov M; Wilson-Rawls J; Cole SE; Moran JL; Russo P; Spinner NB; Kusumi K; Loomes KM
Hepatology; 2008 Dec; 48(6):1989-97. PubMed ID: 19026002
[TBL] [Abstract][Full Text] [Related]
3. The role of notch signaling in the development of intrahepatic bile ducts.
Kodama Y; Hijikata M; Kageyama R; Shimotohno K; Chiba T
Gastroenterology; 2004 Dec; 127(6):1775-86. PubMed ID: 15578515
[TBL] [Abstract][Full Text] [Related]
4. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
Andersson ER; Chivukula IV; Hankeova S; Sjöqvist M; Tsoi YL; Ramsköld D; Masek J; Elmansuri A; Hoogendoorn A; Vazquez E; Storvall H; Netušilová J; Huch M; Fischler B; Ellis E; Contreras A; Nemeth A; Chien KC; Clevers H; Sandberg R; Bryja V; Lendahl U
Gastroenterology; 2018 Mar; 154(4):1080-1095. PubMed ID: 29162437
[TBL] [Abstract][Full Text] [Related]
5. Human Jagged 1 mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor.
Yuan ZR; Kobayashi N; Kohsaka T
J Mol Biol; 2006 Feb; 356(3):559-68. PubMed ID: 16403414
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
McCright B; Lozier J; Gridley T
Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
[TBL] [Abstract][Full Text] [Related]
7. Microarray data reveal relationship between Jag1 and Ddr1 in mouse liver.
Underkoffler LA; Carr E; Nelson A; Ryan MJ; Schulz R; Loomes KM
PLoS One; 2013; 8(12):e84383. PubMed ID: 24391948
[TBL] [Abstract][Full Text] [Related]
8. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi).
Thakurdas SM; Lopez MF; Kakuda S; Fernandez-Valdivia R; Zarrin-Khameh N; Haltiwanger RS; Jafar-Nejad H
Hepatology; 2016 Feb; 63(2):550-65. PubMed ID: 26235536
[TBL] [Abstract][Full Text] [Related]
9. [From gene to disease: arteriohepatic dysplasia or Alagille syndrome].
Brooks AS; Dooijes D
Ned Tijdschr Geneeskd; 2003 Jun; 147(25):1213-5. PubMed ID: 12848056
[TBL] [Abstract][Full Text] [Related]
10. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage.
Loomes KM; Russo P; Ryan M; Nelson A; Underkoffler L; Glover C; Fu H; Gridley T; Kaestner KH; Oakey RJ
Hepatology; 2007 Feb; 45(2):323-30. PubMed ID: 17366661
[TBL] [Abstract][Full Text] [Related]
11. TGFβ signaling controls intrahepatic bile duct development may through regulating the Jagged1-Notch-Sox9 signaling axis.
Wang W; Feng Y; Aimaiti Y; Jin X; Mao X; Li D
J Cell Physiol; 2018 Aug; 233(8):5780-5791. PubMed ID: 29194611
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy.
Lorent K; Yeo SY; Oda T; Chandrasekharappa S; Chitnis A; Matthews RP; Pack M
Development; 2004 Nov; 131(22):5753-66. PubMed ID: 15509774
[TBL] [Abstract][Full Text] [Related]
13. Bile Ducts in Regenerative Liver Nodules of Alagille Patients Are Not the Result of Genetic Mosaicism.
Rougemont AL; Alvarez F; McLin VA; Guiochon-Mantel A; Bouligand J; Clément S; Tonson La Tour A; Wildhaber BE; Rubbia-Brandt L; Sartelet H
J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):91-3. PubMed ID: 25643021
[TBL] [Abstract][Full Text] [Related]
14. Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients.
Humphreys R; Zheng W; Prince LS; Qu X; Brown C; Loomes K; Huppert SS; Baldwin S; Goudy S
Hum Mol Genet; 2012 Mar; 21(6):1374-83. PubMed ID: 22156581
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular genetics of Alagille syndrome.
Krantz ID; Piccoli DA; Spinner NB
Curr Opin Pediatr; 1999 Dec; 11(6):558-64. PubMed ID: 10590916
[TBL] [Abstract][Full Text] [Related]
16. Renal involvement and the role of Notch signalling in Alagille syndrome.
Kamath BM; Spinner NB; Rosenblum ND
Nat Rev Nephrol; 2013 Jul; 9(7):409-18. PubMed ID: 23752887
[TBL] [Abstract][Full Text] [Related]
17. ASO silencing of a glycosyltransferase, Poglut1 , improves the liver phenotypes in mouse models of Alagille syndrome.
Niknejad N; Fox D; Burwinkel JL; Zarrin-Khameh N; Cho S; Soriano A; Cast AE; Lopez MF; Huppert KA; Rigo F; Huppert SS; Jafar-Nejad P; Jafar-Nejad H
Hepatology; 2023 Nov; 78(5):1337-1351. PubMed ID: 37021797
[TBL] [Abstract][Full Text] [Related]
18. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome.
Deutsch GH; Sokol RJ; Stathos TH; Knisely AS
Pediatr Dev Pathol; 2001; 4(6):559-63. PubMed ID: 11826362
[TBL] [Abstract][Full Text] [Related]
19. The DSL domain in mutant JAG1 ligand is essential for the severity of the liver defect in Alagille syndrome.
Yuan ZR; Okaniwa M; Nagata I; Tazawa Y; Ito M; Kawarazaki H; Inomata Y; Okano S; Yoshida T; Kobayashi N; Kohsaka T
Clin Genet; 2001 May; 59(5):330-7. PubMed ID: 11359464
[TBL] [Abstract][Full Text] [Related]
20. Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.
Hofmann JJ; Briot A; Enciso J; Zovein AC; Ren S; Zhang ZW; Radtke F; Simons M; Wang Y; Iruela-Arispe ML
Development; 2012 Dec; 139(23):4449-60. PubMed ID: 23095891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
